Millennium Management’s Tarsus Pharmaceuticals TARS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-30,000
Closed -$1.89M – 6521
2026
Q2
$1.89M Hold
30,000
– – ﹤0.01% 3866
2026
Q1
$2.1M Buy
30,000
+10,000
+50% +$699K ﹤0.01% 3831
2025
Q4
$1.64M Buy
+20,000
New +$1.49M ﹤0.01% 4105

Other funds holding TARS

Millennium Management's TARS Position: Q3 2026 in Review

Millennium Management reduced its Tarsus Pharmaceuticals (TARS) stake by 23% in Q3 2026, selling an estimated $23.2M and leaving 1,093,868 shares worth $85.5M. The position accounts for 0.03% of the portfolio, ranked #601.

Millennium Management first reported a position in TARS in Q4 2020 and has held it in 17 quarters since. The position peaked at $89.8M in Q2 2026. 255 funds tracked by Wall St. Rank hold TARS as of Q3 2026.

  • Millennium Management held 1,093,868 shares of Tarsus Pharmaceuticals worth $85.5M as of Q3 2026.
  • Millennium Management sold 333,256 Tarsus Pharmaceuticals shares in Q3 2026, an estimated $23.2M.
  • Tarsus Pharmaceuticals made up 0.03% of Millennium Management's portfolio in Q3 2026, its #601 holding.
  • Millennium Management first reported a position in Tarsus Pharmaceuticals in Q4 2020 and has held it in 17 quarters since.
  • Millennium Management's Tarsus Pharmaceuticals position peaked at $89.8M in Q2 2026.
  • 255 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q3 2026.

Based on Millennium Management's 13F filing for Q3 2026, filed 16 Nov 2026.